Jacinta Okeke
Psychiatric/Mental Health · Lakeland, FLNPI 1861975575
Payments from drug & device makers
Across 112 payments — averaging $35.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$646
- Otsuka America Pharmaceutical, Inc.$492
- Johnson & Johnson$414
- AstraZeneca$363
- Incyte Corporation$335
- Alkermes, Inc.$311
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,89399%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $646 |
| Otsuka America Pharmaceutical, Inc. | 13 | $492 |
| Johnson & Johnson | 13 | $414 |
| AstraZeneca | 3 | $363 |
| Incyte Corporation | 4 | $335 |
| Alkermes, Inc. | 15 | $311 |
| Neurocrine Biosciences, Inc. | 7 | $192 |
| E.r. Squibb & Sons, L.L.C. | 6 | $147 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $127 |
| Amgen | 1 | $125 |
| Boston Scientific | 1 | $102 |
| AbbVie | 2 | $100 |
| Abbott | 1 | $97 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $94 |
| Evoke Pharma, Inc. | 1 | $81 |
| Genentech USA, Inc. | 1 | $76 |
| Esperion Therapeutics, Inc. | 1 | $75 |
| Medtronic | 2 | $39 |
| Novo Nordisk | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$242
- ABILIFY MAINTENA$239
- KRYSTEXXA$125
- Austedo XR$125
- JAKAFI$125
- AIRSUPRA$121
- WATCHMAN FLX$102
How this compares
$3,921 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 131 | $373,493 |
| Austedo XrDeutetrabenazine | 28 | $186,004 |
| Abilify MaintenaAripiprazole | 50 | $146,378 |
| IngrezzaValbenazine Tosylate | 18 | $137,772 |
| LybalviOlanzapine/Samidorphan Malate | 62 | $99,851 |
| AristadaAripiprazole Lauroxil | 26 | $91,115 |
| Risperdal ConstaRisperidone Microspheres | 13 | $35,386 |
| RexultiBrexpiprazole | 26 | $34,794 |
| VraylarCariprazine Hcl | 20 | $28,109 |
| Paliperidone ErPaliperidone | 20 | $13,712 |
| Olanzapine | 162 | $8,983 |
| Aripiprazole | 76 | $5,445 |
| Clozapine | 47 | $4,960 |
| Haloperidol Decanoate | 59 | $3,072 |
| Divalproex Sodium ErDivalproex Sodium | 84 | $3,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $414 | $408,879144 claims |
| Alkermes, Inc.Lybalvi, Aristada | $311 | $190,96688 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $646 | $186,00428 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $492 | $181,17276 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $192 | $137,77218 claims |
| AbbVieVraylar | $100 | $28,10920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Lakeland
- Julie PetersonLakeland$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.